Lv0
0 积分 2023-04-11 加入
Immune regulation by 4‐1BB and 4‐1BBL: complexities and challenges
8天前
已完结
Engineering CD3/CD137 dual specificity into a DLL3-targeted T-cell engager enhances T-cell infiltration and efficacy against small cell lung cancer
8天前
已完结
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
30天前
已完结
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
1个月前
已完结
Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome
1个月前
已完结
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL
1个月前
已完结
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity
1个月前
已关闭
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity
1个月前
已关闭
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
皖公网安备34019202002308
